Search

Liver cancer is one of the most prevalent cancers and the third leading cause of cancer-related deaths worldwide. Liver cancer is insensitive to chemotherapeutic drugs due to its intrinsic or acquired drug resistance and the inability of delivering sufficient drugs to tumors via current chemotherapy. The emergence of nanomedicines offers a potential solution for this challenge. Nanomedicines utilize nanoscale or nanostructured materials in medicines for particular medical purposes. In this review, we illustrate the recent developments of various nanomedicines for liver cancer by presenting selected examples at different stages. Diverse nanomaterials, varied targeting moieties, and specific strategies for controlled release of nanomedicines for liver cancer therapy are summarized. Multifunctional nanomedicines for liver cancer are also discussed. This comprehensive review is aimed at providing quick access for readers to the cutting-edge nanomedicines in liver cancer therapy. [ABSTRACT FROM AUTHOR]

We combined silver and iron oxide nanoparticles to make unique Ag@Fe2O3yolk–shell multifunctional nanoparticles by the Kirkendall effect. After the surface functionalization using glucose, the Ag@Fe2O3–Glu conjugates exhibited both high capture efficiency of bacteria and potent antibacterial activity. The Ag@Fe2O3yolk–shell nanostructures may offer a unique multifunctional platform for simultaneous rapid detection and capture of bacteria and safe detoxification treatment. [ABSTRACT FROM AUTHOR]

We have developed a convenient strategy for preparing color-tunable fluorescent-magnetic core/shell multifunctional nanocrystals, which exhibit excellent photoluminescence (PL) properties (fluorescing tunably from 550 nm to 630 nm by modifying the shell thickness) and ferromagnetic material properties (a magnetization of 4.4 emu g-1 and a coercivity of 95 Oe). [ABSTRACT FROM AUTHOR]